A detailed history of State Of Wisconsin Investment Board transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 18,931 shares of KROS stock, worth $865,146. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,931
Previous 28,891 34.47%
Holding current value
$865,146
Previous $1.15 Million 9.15%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$41.26 - $70.48 $410,949 - $701,980
-9,960 Reduced 34.47%
18,931 $1.25 Million
Q4 2023

Feb 12, 2024

BUY
$27.12 - $41.05 $59,202 - $89,612
2,183 Added 8.17%
28,891 $1.15 Million
Q3 2023

Nov 14, 2023

BUY
$31.57 - $43.02 $378,019 - $515,121
11,974 Added 81.27%
26,708 $851,000
Q2 2023

Aug 14, 2023

SELL
$37.26 - $51.01 $119,418 - $163,487
-3,205 Reduced 17.87%
14,734 $592,000
Q1 2023

May 15, 2023

BUY
$41.44 - $59.32 $104,097 - $149,011
2,512 Added 16.28%
17,939 $765,000
Q4 2022

Feb 14, 2023

BUY
$39.45 - $51.77 $40,909 - $53,685
1,037 Added 7.21%
15,427 $740,000
Q3 2022

Nov 14, 2022

BUY
$27.8 - $40.12 $11,231 - $16,208
404 Added 2.89%
14,390 $541,000
Q2 2022

Aug 15, 2022

SELL
$26.03 - $67.04 $101,881 - $262,394
-3,914 Reduced 21.87%
13,986 $386,000
Q1 2021

May 17, 2021

SELL
$54.0 - $75.28 $10,800 - $15,056
-200 Reduced 1.1%
17,900 $1.1 Million
Q4 2020

Feb 03, 2021

BUY
$36.0 - $82.74 $248,400 - $570,906
6,900 Added 61.61%
18,100 $1.28 Million
Q2 2020

Aug 12, 2020

BUY
$20.08 - $40.39 $224,895 - $452,368
11,200 New
11,200 $420,000

Others Institutions Holding KROS

About Keros Therapeutics, Inc.


  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $1.18B
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.